HuagongsheHuagongshe Chemistry Print Report · For research reference only
tert-Butyl [(2S)-2-(3,4-dichlorophenyl)-4-oxobutyl]methylcarbamate → tert-Butyl {(2S)-2-(3,4-dichlorophenyl)-4-[3-(4-hydroxypiperidin-1-yl)azetidin-1-yl]butyl}methylcarbamate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | tert-Butyl [(2S)-2-(3,4-dichlorophenyl)-4-oxobutyl]methylcarbamate | HCID 15433413 | — |
| Reactant | 1-(3-Azetidinyl)-4-piperidinol dihydrochloride | HCID 45789920 | — |
| Reactant | 4-Azetidin-3-ylthiomorpholine dihydrochloride | HCID 68976386 | — |
| Reactant | Tert-butyl [2-(4-fluorophenyl)-4-oxobutyl]methylcarbamate | HCID 86606881 | — |
| Product | tert-Butyl {(2S)-2-(3,4-dichlorophenyl)-4-[3-(4-hydroxypiperidin-1-yl)azetidin-1-yl]butyl}methylcarbamate | HCID 86606883 | — |
Reaction Steps
The compound was synthesized in an analogous way to that of Method 3d but using 1-azetidin-3-ylpiperidin-4-ol dihydrochloride (see Meth 15) and tert-butyl [(2S)-2-(3,4-dichlorophenyl)-4-oxobutyl]methylcarbamate (see WO 95/05377) rather than 4-azetidin-3-ylthiomorpholine dihydrochloride and tert-butyl [2-(4-fluorophenyl)-4-oxobutyl]methylcarbamate (yield, 35%). 1H NMR (500 MHz, CDCl3): 1.3 (m, 2H), 1.4 (s, 9H), 1.5-3.8 (cm, 23H), 7.0 (dd, 1H), 7.2-7.4 (m, 2H), LCMS: m/z 487 (M+1)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07402581B2 |
| Source dataset | uspto-grants-2008_07 |
| ORD ID | ord-69de515fe78c46f283688f62002f66b3 |
| Source note | uspto-grants-2008_07 |